Late relapses in acute promyelocytic leukaemia

Acta Haematologica

Volumn 117, Issue 2, 2007, Pages 106-108

  Latagliata, Roberto ^a,e   Carmosino, Ida ^a   Breccia, Massimo ^a   Minni, Antonio ^a   Testi, Anna ^a   Iorio, Nicol ^a   Lo Coco, Francesco ^b   Avvisati, Giuseppe ^c   Petti, Maria Concetta ^d   Mandelli, Franco ^a   Cimino, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e NONE   (Italy)

Author keywords

Acute promyelocytic leukaemia; All trans retinoic acid; Extramedullary relapse; Late relapse

Indexed keywords

CYTARABINE; MITOXANTRONE; RETINOIC ACID;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MASTOID; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYTARABINE; FEMALE; HUMANS; IDARUBICIN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MASTOID; MITOXANTRONE; RECURRENCE; TIME FACTORS; TRETINOIN;

EID: 33847067001     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097385     Document Type: Article

References (9)

1. Sucic M, Zadro R, Burazer B, Labar B, Nemet D, Mrsic M, Aurer I, Mrsic S, Hitrec V, Boban D, Markovic-Glamocak M, Batinic D, Uzarevic B, Stavljenic-Rukavina A: Acute promyelocytic leukemia M3: cytomorphologic, immunophenotypic, cytogenetic, and molecular variants. J Hematother Stem Cell Res 2002;11:941-950.
2. Mandelli F, Diverio D, Avvisati G, Luciano A, Barbui T, Bernasconi C, Broccia G, Cerri R, Falda M, Fioritoni G, Leoni F, Liso V, Petti MC, Rodeghiero F, Saglio G, Vegna ML, Visani G, Jehn U, Willemze R, Muus P, Pelicci PG, Biondi A, Lo-Coco F: Molecular remission in PML/RARα-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Blood 1997;90:1014-1021.
3. Wang Z, Sun G, Shen Z, Chen S, Chen Z: Differentiation therapy for acute promyelocytic leukemia with all-trans retinoid acid: 10-year experience of its application. Chin Med J (Engl) 1999;112:963-967.
4. Ferrara F, Selleri C, Mele G, Serio B, Palmieri S, Pocali B, Pane F, Rotoli B: Late relapse of acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: report of two cases. Ann Hematol 2004;83:484-486.
5. Avvisati G, Petti MC, Lo-Coco F, Vegna ML, Amadori S, Baccarani M, Cantore N, Di Bona E, Ferrara F, Fioritoni G, Gallo E, Invernizzi R, Lazzarino M, Liso V, Mariani G, Ricciuti F, Selleri C, Sica S, Veneri D, Mandelli F: Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP-0389 with 7 years of minimal follow-up. Blood 2002;100:3141-3146.
6. Ko BS, Tang JL, Chen YC, Yao M, Wang CH, Shen MC, Thien HF: Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - the occurrence of retinoic acid syndrome is a risk factor. Leukemia 1999;13:1406-1408.
7. Breccia M, Carmosino I, Diverio D, De Santis S, De Propris MS, Romano A, Petti MC, Mandelli F, Lo-Coco F: Early detection of meningeal localization in acute promyelocytic leukaemia patients with high presenting leucocyte count. Br J Haematol 2003;120:266-270.
8. Specchia G, Lo-Coco F, Vignetti M, Avvisati G, Fazi P, Albano F, Di Raimondo F, Martino B, Ferrara F, Selleri C, Liso V, Mandelli F: Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. J Clin Oncol 2001;19:4023-4028.
9. Leskinen K: Complications of acute otitis media in children. Curr Allergy Asthma Rep 2005;5:308-312.